BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

678 related articles for article (PubMed ID: 11503186)

  • 1. [Changes in microcirculation and selected laboratory parameters in the early stages of diabetic microangiopathy].
    Skrha J; Prázný M; Kvasnicka J; Kalvodová B
    Cas Lek Cesk; 2001 Jun; 140(12):370-4. PubMed ID: 11503186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of laser-Doppler flowmetry with biochemical indicators of endothelial dysfunction related to early microangiopathy in Type 1 diabetic patients.
    Skrha J; Prázný M; Haas T; Kvasnicka J; Kalvodová B
    J Diabetes Complications; 2001; 15(5):234-40. PubMed ID: 11522496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between peripheral diabetic neuropathy and microvascular reactivity in patients with type 1 and type 2 diabetes mellitus -- neuropathy and microcirculation in diabetes.
    Kasalová Z; Prázný M; Skrha J
    Exp Clin Endocrinol Diabetes; 2006 Feb; 114(2):52-7. PubMed ID: 16570233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood flow in the skin of type 1 diabetic patients before and after combined pancreas/kidney transplantation.
    Eberl N; Piehlmeier W; Dachauer S; König A; Land W; Landgraf R
    Diabetes Metab Res Rev; 2005; 21(6):525-32. PubMed ID: 15880479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil surface expression of CD11b and CD62L in diabetic microangiopathy.
    Mastej K; Adamiec R
    Acta Diabetol; 2008 Sep; 45(3):183-90. PubMed ID: 18496641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diastolic dysfunction and abnormalities of the microcirculation in type 2 diabetes.
    Brooks BA; Franjic B; Ban CR; Swaraj K; Yue DK; Celermajer DS; Twigg SM
    Diabetes Obes Metab; 2008 Sep; 10(9):739-46. PubMed ID: 17941867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy.
    Targher G; Bertolini L; Zoppini G; Zenari L; Falezza G
    Diabet Med; 2005 Aug; 22(8):999-1004. PubMed ID: 16026364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent arterial stiffness and endothelial dysfunction following successful pancreas-kidney transplantation in Type 1 diabetes.
    Stadler M; Theuer E; Anderwald C; Hanusch-Enserer U; Auinger M; Bieglmayer C; Quehenberger P; Bischof M; Kästenbauer T; Wolzt M; Wagner O; Prager R
    Diabet Med; 2009 Oct; 26(10):1010-8. PubMed ID: 19900233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Assessment of changes in peripheral microcirculation in type I diabetics with laser doppler flowmetry].
    Hofírek I; Sochor O; Olovský J
    Vnitr Lek; 2004 Nov; 50(11):836-41. PubMed ID: 15648963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [IGFBP-1 and its protective role in the pathogenesis of microangiopathy in type 1 diabetes mellitus].
    Krsek M; Prázný M; Skrha J; Justová V; Lacinová Z
    Cas Lek Cesk; 2001 Apr; 140(8):234-7. PubMed ID: 11392040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial.
    De Jager J; Kooy A; Lehert P; Bets D; Wulffelé MG; Teerlink T; Scheffer PG; Schalkwijk CG; Donker AJ; Stehouwer CD
    J Intern Med; 2005 Jan; 257(1):100-9. PubMed ID: 15606381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microvascular Reactivity and Endothelial Function in Type 2 Diabetic Patients with Hyperlipidemia Treated with Simvastatin: 3-year Follow-up.
    Prázný M; Kasalová Z; Mazoch J; Kvasnicka J; Skrha J
    Prague Med Rep; 2009; 110(4):290-300. PubMed ID: 20059881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in serum levels of IGF-I and its binding proteins and their relation to microcirculation in obese patients].
    Krsek M; Prázný M; Sucharda P; Marek J; Justová V; Lacinová Z
    Vnitr Lek; 2001 Dec; 47(12):847-51. PubMed ID: 11826548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: a placebo-controlled randomized clinical trial.
    Caballero AE; Saouaf R; Lim SC; Hamdy O; Abou-Elenin K; O'Connor C; Logerfo FW; Horton ES; Veves A
    Metabolism; 2003 Feb; 52(2):173-80. PubMed ID: 12601628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulation and fibrinolysis variables in pregnant women with type 1 diabetes mellitus.
    Bronisz A; Rosc D; Bronisz M; Szymanski W; Junik R
    Med Sci Monit; 2008 Nov; 14(11):CR574-9. PubMed ID: 18971874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of oxidative stress and fibrinolysis in diabetes mellitus.
    Skrha J; Hodinár A; Kvasnicka J; Hilgertová J
    Diabet Med; 1996 Sep; 13(9):800-5. PubMed ID: 8891455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial and neural regulation of skin microvascular blood flow in patients with diabetic peripheral neuropathy: effect of treatment with the isoform-specific protein kinase C beta inhibitor, ruboxistaurin.
    Brooks B; Delaney-Robinson C; Molyneaux L; Yue DK
    J Diabetes Complications; 2008; 22(2):88-95. PubMed ID: 18280438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Microvascular reactivity in type 2 diabetes mellitus and its relation to IGF-I and its binding proteins].
    Krsek M; Prázný M; Skrha J; Justová V; Lacinová Z; Haas T
    Vnitr Lek; 2003 Jul; 49(7):535-40. PubMed ID: 12931435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble adhesion molecules (sICAM-1, sVCAM-1) and selectins (sE selectin, sP selectin, sL selectin) levels in children and adolescents with obesity, hypertension, and diabetes.
    Glowinska B; Urban M; Peczynska J; Florys B
    Metabolism; 2005 Aug; 54(8):1020-6. PubMed ID: 16092051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Selectins in the pathogenesis and diagnosis of early atherosclerotic changes in children and adolescents with risk factors (obesity, hypertension and diabetes)].
    Głowińska B; Urban M; Peczyńska J; Florys B
    Przegl Lek; 2004; 61(9):935-9. PubMed ID: 15803902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.